Chinese Journal of Cancerindexed by SCI
《癌症》杂志
BMC

About the cover
About the cover

Nov. 2015; Volume 34 Issue 11

In November 2005, the first oncolytic virus, a genetically modified adenovirus, named H101 by Shanghai Sunway Biotech, gained regulatory approval from China's State Food and Drug Administration (SFDA) for the treatment of head and neck cancer.


Highlight
miR-506: a regulator of chemo-sensitivity through suppression of the RAD51-homologous recombination axis
Guoyan Liu, Fengxia Xue and Wei Zhang
[ Abstract  1200]  [ PDF Full-text  965]   [ HTML Full-text  527]    Epub: 2015-9-14  doi: 10.1186/s40880-015-0049-z
Review
The reversal of antineoplastic drug resistance in cancer cells by β-elemene
Guan-Nan Zhang, Charles R. Ashby, Yun-Kai Zhang, Zhe-Sheng Chen* and Huiqin Guo
[ Abstract  1167]  [ PDF Full-text  1158]   [ HTML Full-text  559]    Epub: 2015-9-14  doi: 10.1186/s40880-015-0048-0
Targeted therapy: resistance and re-sensitization
Dao-Hong Chen and Xiao-Shi Zhang
[ Abstract  1164]  [ PDF Full-text  890]   [ HTML Full-text  778]    Epub: 2015-9-14  doi: 10.1186/s40880-015-0047-1
Original Article
The updated incidences and mortalities of major cancers in China, 2011
Wanqing Chen, Rongshou Zheng, Hongmei Zeng and Siwei Zhang
[ Abstract  749]  [ PDF Full-text  920]   [ HTML Full-text  677]    Epub: 2015-9-14  doi: 10.1186/s40880-015-0042-6
Incidence and mortality of liver cancer in China in 2011
Ting-Ting Zuo, Rong-Shou Zheng, Si-Wei Zhang, Hong-Mei Zeng and Wan-Qing Chen
[ Abstract  709]  [ PDF Full-text  793]   [ HTML Full-text  764]    Epub: 2015-10-15  doi: 10.1186/s40880-015-0056-0
Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma
Li-Ling Luo, Lei Zhao, Mian Xi, Li-Ru He, Jing-Xian Shen,Qiao-Qiao Li, Shi-Liang Liu, Peng Zhang, Dan Xie and Meng-Zhong Liu
[ Abstract  883]  [ PDF Full-text  945]   [ HTML Full-text  711]    Epub: 2015-9-14  doi: 10.1186/s40880-015-0046-2
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma
Yuankai Shi, Ping Zhou, Xiaohong Han, Xiaohui He, Shengyu Zhou, Peng Liu, Jianliang Yang, Changgong Zhang, Lin Gui, Yan Qin, Sheng Yang, Liya Zhao, Jiarui Yao and Shuxiang Zhang
[ Abstract  1073]  [ PDF Full-text  995]   [ HTML Full-text  884]    Epub: 2015-9-14  doi: 10.1186/s40880-015-0045-3
Brain metastasis in children with stage 4 neuroblastoma after multidisciplinary treatment
Jia Zhu, Juan Wang, Zi-Jun Zhen, Su-Ying Lu, Fei Zhang, Fei-Fei Sun, Peng-Fei Li, Jun-Ting Huang, Rui-Qing Cai and Xiao-Fei Sun
[ Abstract  880]  [ PDF Full-text  1035]   [ HTML Full-text  840]    Epub: 2015-9-14  doi: 10.1186/s40880-015-0038-2




CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CJC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China